文献速递皮肤感染皮肤肿瘤

抗逆转录病毒治疗时代HIV感染者非角质形成细胞皮肤癌风险

Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy.
PubMed 文献 · J Invest Dermatol · 2022-10-07

基于美国12个州/地区HIV与癌症登记链接数据(1996‒2018),在585,706名HIV感染者中随访4,575,794人年,诊断2,743例非角质形成细胞皮肤癌(NKSC)。卡波西肉瘤标化发病比为147(95%CI 141‒153),弥漫大B细胞淋巴瘤为5.19(95%CI 3.13‒8.11),梅克尔细胞癌为3.15(95%CI 1.93‒4.87);黑色素瘤、附件癌和肉瘤发病率未升高。

要点

  • HIV感染者卡波西肉瘤标化发病比147(95%CI 141‒153),为最常见NKSC(82%)。
  • 弥漫大B细胞淋巴瘤和梅克尔细胞癌发病升高仅见于既往诊断艾滋病者。
  • 黑色素瘤、附件癌和肉瘤发病率与一般人群相似,未升高。

核心结论

  • 抗逆转录病毒治疗时代大多数NKSC风险与一般人群相似,提示无NKSC危险因素的HIV感染者可能不需要强化皮肤监测。

研究设计与样本

  • 使用美国12个州/地区HIV与癌症登记链接数据,纳入585,706名HIV感染者,随访4,575,794人年,计算27种NKSC的标化发病比并与一般人群比较,采用泊松回归评估危险因素。

主要发现

  • 共诊断2,743例NKSC,卡波西肉瘤最常见(82%),其次为黑色素瘤(12%)和皮肤淋巴瘤(2.6%)。
  • 病毒相关NKSC发病升高:卡波西肉瘤标化发病比=147(95%CI 141‒153),弥漫大B细胞淋巴瘤标化发病比=5.19(95%CI 3.13‒8.11),梅克尔细胞癌标化发病比=3.15(95%CI 1.93‒4.87)。
  • 弥漫大B细胞淋巴瘤和梅克尔细胞癌发病升高仅见于既往诊断艾滋病的HIV感染者。
  • 卡波西肉瘤风险在男男性行为者中最高。
  • 黑色素瘤、附件癌和肉瘤发病率未升高;黑色素瘤和梅克尔细胞癌不成比例地发生于日光暴露皮肤,支持紫外线辐射在其发生中的作用。

临床怎么用

  • 原文结论提示无NKSC危险因素的HIV感染者可能不需要强化皮肤监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antiretroviral therapy may alter susceptibility to nonkeratinocyte skin cancers (NKSCs) by improving immunity in people living with HIV. Using linked data from HIV and cancer registries in 12 states/regions in the United States during the antiretroviral therapy era (1996‒2018), we calculated standardized incidence ratios for 27 NKSCs, comparing incidence with that of the general population. Risk factors for NKSCs were evaluated using Poisson regression. There were 2,743 NKSCs diagnosed in 585,706 people living with HIV followed for 4,575,794 person-years. Kaposi sarcoma was the most common cancer (82%), followed by melanoma (12%) and cutaneous lymphoma (2.6%). Incidence was elevated for virus-related NKSCs: Kaposi sarcoma (standardized incidence ratio = 147, 95% confidence interval = 141‒153), diffuse large B-cell lymphoma (standardized incidence ratio = 5.19, 95% confidence interval = 3.13‒8.11), and Merkel cell carcinoma (standardized incidence ratio = 3.15, 95% confidence interval = 1.93‒4.87); elevated incidence for diffuse large B-cell lymphoma and Merkel cell carcinoma was observed only among people living with HIV with a previously acquired immunodeficiency syndrome diagnosis. Kaposi sarcoma risk was highest among men who have sex with men. Incidence was not increased for melanoma, adnexal carcinomas, and sarcomas. Melanoma and Merkel cell carcinoma arose disproportionately on sun-exposed skin, supporting a role for UVR in their development. In conclusion, risk for most NKSCs was similar to that of the general population during the antiretroviral therapy era, suggesting that people living with HIV without NKSC risk factors may not require intensive skin surveillance.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Luu YT, Luo Q, Horner MJ, et al. Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy. J Invest Dermatol. 2022. PMID: 36216206. doi:10.1016/j.jid.2022.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。